Literature DB >> 106986

Effects of nitroglycerin on echocardiographic measurements of left ventricular wall thickness and regional myocardial performance during acute coronary ischemia.

R R Komer, A Edalji, W B Hood.   

Abstract

The effects of nitroglycerin on regional left ventricular performance, assessed by echocardiographic techniques, were investigated in anesthetized, open-chest dogs during acute myocardial ischemia. During transient occlusion of the left anterior descending coronary artery, there was end-diastolic thinning and marked reduction in systolic thickening in the central ischemic zone. Similar changes of lesser degree were noted in the border zone. The normal zone was unaffected. Infusion of nitroglycerin during ischemia in dosages of 2.5--50 microgram/kg/min reduced left ventricular end-diastolic pressure without changing the abnormalities of systolic wall thickening. Effects of bolus injections of 20 and 50 microgram/kg of nitroglycerin were similar, although this also lowered aortic pressure. In a subgroup of animals in which nitroglycerin infusion was unaccompanied by tachycardia, there was also no evidence that ischemic dysfunction was altered. We conclude that nitroglycerin does not improve regional myocardial performance in acutely ischemic canine myocardium. The decrease in preload is probably entirely due to the peripheral effects of the agent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106986     DOI: 10.1161/01.cir.59.5.926

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2 in total

1.  Systemic and regional myocardial responses to AR-L 115 BS, a positive inotropic imidazo-pyridine, in the absence or in the presence of the bradycardiac action of alinidine.

Authors:  P D Verdouw; J M Hartog; A M Ruggeman
Journal:  Basic Res Cardiol       Date:  1981 May-Jun       Impact factor: 17.165

2.  The effects of pretreatment with nitroglycerin on ischemic left ventricular dysfunction during coronary angioplasty.

Authors:  I Amende; G Herrmann; R Simon; W P Hood; P Wenzlaff; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.